Long-term results of intravitreal bevacizumab for choroidal neovascularisation in pathological myopia
British Journal of Ophthalmology, 06/06/2012
Clinical Article
et al. – A regimen of three monthly intravitreal bevacizumab injections yielded effective and sustained results in the treatment of myopic choroidal neovascularisation at 3?years of follow–up. Initial best corrected visual acuity (BCVA) and age were the factors that correlated independently with BCVA outcome



